Factor-V Leiden Mutation Detection G1691 A Mutation

The Factor-V Leiden Mutation Detection G1691 A Mutation assay utilizes real-time PCR to detect the presence of the Factor V Leiden mutation, specifically the G1691A mutation, in the blood. The test is recommended to identify individuals with an increased risk of venous thrombosis. or if a patient has an inherited gene mutation that increases their risk of developing blood clots, including deep venous thrombosis (DVT) and/or venous thromboembolism (VTE). It is also advised in patients with clinically suspected thrombophilia or a family history of the Factor V Leiden mutation. The symptoms in the legs include pain, redness, warmth, and swelling in the areas of blood clots. In the lungs, the symptoms include shortness of breath, cough, difficulty in breathing, and chest pain.

Your doctor may recommend the Factor-V Leiden Mutation Detection G1691 A Mutation test if you have symptoms or a family history of blood clotting disorders, if you have symptoms suggestive of deep venous thrombosis or venous thromboembolism, if you have a personal or family history of Factor V Leiden mutation, and in certain medical conditions, such as recurrent miscarriages or unexplained thrombosis. By identifying the presence of the Factor V Leiden mutation, appropriate preventive measures and treatment strategies can be implemented to mitigate the risk of venous thrombotic events.

Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.